Protein interaction network of alternatively spliced NudCD1 isoforms.
Patrick Asselin-MullenAnaïs ChauvinMarie-Line DuboisRomain DrissiDominique LévesqueFrançois-Michel BoisvertPublished in: Scientific reports (2017)
NudCD1, also known as CML66 or OVA66, is a protein initially identified as overexpressed in patients with chronic myelogenous leukemia. The mRNA of NudCD1 is expressed in heart and testis of normal tissues, and is overexpressed in several cancers. Previous studies have shown that the expression level of the protein correlates with tumoral phenotype, possibly interacting upstream of the Insulin Growth Factor - 1 Receptor (IGF-1R). The gene encoding the NudCD1 protein consists of 12 exons that can be alternative spliced, leading to the expression of three different isoforms. These isoforms possess a common region of 492 amino acids in their C-terminus region and have an isoform specific N-terminus. To determine the distinct function of each isoforms, we have localised the isoforms within the cells using immunofluorescence microscopy and used a quantitative proteomics approach (SILAC) to identify specific protein interaction partners for each isoforms. Localization studies showed a different subcellular distribution for the different isoforms, with the first isoform being nuclear, while the other two isoforms have distinct cytoplasmic and nuclear location. We found that the different NudCD1 isoforms have unique interacting partners, with the first isoform binding to a putative RNA helicase named DHX15 involved in mRNA splicing.
Keyphrases
- binding protein
- amino acid
- growth factor
- protein protein
- poor prognosis
- type diabetes
- high resolution
- mass spectrometry
- heart failure
- acute myeloid leukemia
- gene expression
- cell proliferation
- oxidative stress
- single molecule
- long non coding rna
- young adults
- cell death
- hepatitis c virus
- high throughput
- signaling pathway
- high speed
- endoplasmic reticulum stress
- growth hormone
- chronic myeloid leukemia